These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8006932)

  • 1. Consecutive mutations leading to the emergence in vivo of imipenem resistance in a clinical strain of Enterobacter aerogenes.
    Tzouvelekis LS; Tzelepi E; Kaufmann ME; Mentis AF
    J Med Microbiol; 1994 Jun; 40(6):403-7. PubMed ID: 8006932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporinases and impaired permeability.
    Tzouvelekis LS; Tzelepi E; Mentis AF; Vatopoulos AC; Tsakris A
    FEMS Microbiol Lett; 1992 Aug; 74(2-3):195-9. PubMed ID: 1526451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability.
    Bornet C; Davin-Regli A; Bosi C; Pages JM; Bollet C
    J Clin Microbiol; 2000 Mar; 38(3):1048-52. PubMed ID: 10698994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Resistance to imipenem in Enterobacter aerogenes].
    Miró E; Alonso C; Navarro F; Mirelis B; Prats G
    Enferm Infecc Microbiol Clin; 1995 May; 13(5):278-82. PubMed ID: 7779892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and bacteriological study of nosocomial infections due to Enterobacter aerogenes resistant to imipenem.
    de Champs C; Henquell C; Guelon D; Sirot D; Gazuy N; Sirot J
    J Clin Microbiol; 1993 Jan; 31(1):123-7. PubMed ID: 8417016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.
    Quinn JP; DiVincenzo CA; Foster J
    J Infect Dis; 1987 May; 155(5):942-7. PubMed ID: 3549922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An adaptive response of Enterobacter aerogenes to imipenem: regulation of porin balance in clinical isolates.
    Lavigne JP; Sotto A; Nicolas-Chanoine MH; Bouziges N; Pagès JM; Davin-Regli A
    Int J Antimicrob Agents; 2013 Feb; 41(2):130-6. PubMed ID: 23280442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of two resistance mechanisms in a clinical isolate of Enterobacter cloacae with high-level resistance to imipenem.
    Lee EH; Nicolas MH; Kitzis MD; Pialoux G; Collatz E; Gutmann L
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1093-8. PubMed ID: 1929248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbapenem resistance in Enterobacter aerogenes is due to lipopolysaccharide alterations.
    Leying H; Cullmann W; Dick W
    Chemotherapy; 1991; 37(2):106-13. PubMed ID: 2032467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient.
    Thiolas A; Bollet C; La Scola B; Raoult D; Pagès JM
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1354-8. PubMed ID: 15793111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of Enterobacter aerogenes susceptible to beta-lactam antibiotics despite high level beta-lactamase production.
    Mellencamp MA; Roccaforte JS; Preheim LC; Sanders CC; Anene CA; Bittner MJ
    Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):827-30. PubMed ID: 2086219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enterobacter cloacae and E. aerogenes septicemia: emergence of resistant variants (derepressed cephalosporinase) during treatment with third-generation cephalosporins].
    Nauciel C; Philippon A; Ronco E; Pilliot J; Guenounou M; Paul G; Brunel D; Outin HD
    Presse Med; 1985 Mar; 14(12):673-6. PubMed ID: 3157961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes.
    Hopkins JM; Towner KJ
    J Antimicrob Chemother; 1990 Jan; 25(1):49-55. PubMed ID: 2318754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase.
    Fernández-Cuenca F; Rodríguez-Martínez JM; Martínez-Martínez L; Pascual A
    Int J Antimicrob Agents; 2006 Jun; 27(6):549-52. PubMed ID: 16697150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases.
    Chen YG; Zhang Y; Yu YS; Qu TT; Wei ZQ; Shen P; Li LJ
    Int J Antimicrob Agents; 2008 Oct; 32(4):302-7. PubMed ID: 18556176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin.
    Ehrhardt AF; Sanders CC; Thomson KS; Watanakunakorn C; Trujillano-Martin I
    Clin Infect Dis; 1993 Jul; 17(1):120-2. PubMed ID: 8353231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characterization of an extended-spectrum AmpC cephalosporinase with hydrolysing activity against fourth-generation cephalosporins in a clinical isolate of Enterobacter aerogenes selected in vivo.
    Rodríguez-Martínez JM; Fernández-Echauri P; Fernández-Cuenca F; Diaz de Alba P; Briales A; Pascual A
    J Antimicrob Chemother; 2012 Jan; 67(1):64-8. PubMed ID: 22001269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to imipenem, cefepime, and cefpirome associated with mutation in Omp36 osmoporin of Enterobacter aerogenes.
    Thiolas A; Bornet C; Davin-Régli A; Pagès JM; Bollet C
    Biochem Biophys Res Commun; 2004 May; 317(3):851-6. PubMed ID: 15081418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of non-clonal imipenem-nonsusceptible Enterobacter spp. isolates in Korea and their association with porin down-regulation.
    Lee JY; Hong YK; Lee H; Ko KS
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):53-59. PubMed ID: 28336135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.